| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| ARK Investment Management · Cathie Wood | $110.5M | 0.72% | 1.61M | +22% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a WGS trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Feeley KevinChief Financial Officer | Sale at price 84.22 per share. | 1.3K | $108.22K |
| Sep 8, 2026 | Feeley KevinChief Financial Officer | — | 2.5K | — |
| Sep 8, 2026 | Stueland KatherineChief Executive Officer | Sale at price 84.22 per share. | 3.7K | $310.93K |
| Sep 8, 2026 | Stueland KatherineChief Executive Officer | — | 6.5K | — |
| Aug 31, 2026 | Feeley KevinChief Financial Officer | Sale at price 83.84 per share. | 372 | $31.19K |
| Aug 31, 2026 | Feeley KevinChief Financial Officer | — | 717 | — |
| Jun 17, 2026 | Leproust Emily MDirector | — | 3.6K | — |
| Jun 17, 2026 | Pfenniger Richard C JrDirector | — | 3.6K | — |
| Jun 17, 2026 | Ruch JoshuaDirector | — | 3.6K | — |
| Jun 17, 2026 | Meister Keith ADirector and Beneficial Owner of more than 10% of a Class of Security | — | 3.6K | — |
| Jun 17, 2026 | Ryan Jason CDirector | — | 3.6K | — |
| Jun 17, 2026 | Casdin EliDirector and Beneficial Owner of more than 10% of a Class of Security | — | 3.6K | — |
| Jun 15, 2026 | Feeley KevinChief Financial Officer | Sale at price 59.75 - 61.50 per share. | 3.7K | $226.60K |
| Jun 15, 2026 | Feeley KevinChief Financial Officer | — | 7.2K | — |
| Jun 15, 2026 | Stueland KatherineChief Executive Officer | Sale at price 59.75 - 61.50 per share. | 10.5K | $638.10K |
| Jun 15, 2026 | Stueland KatherineChief Executive Officer | — | 18.8K | — |
| Jun 8, 2026 | Feeley KevinChief Financial Officer | Sale at price 53.77 per share. | 1.3K | $68.07K |
| Jun 8, 2026 | Feeley KevinChief Financial Officer | — | 2.5K | — |
| Jun 8, 2026 | Stueland KatherineChief Executive Officer | Sale at price 53.77 per share. | 3.6K | $195.67K |
| Jun 8, 2026 | Stueland KatherineChief Executive Officer | — | 6.5K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -26.0 | -17.2 | -19.4 | -2.1 | -17.3 | 32.0 | -5.2 | 30.3 | -14.8 | -13.1 | −51.7% | ||
| 2025 | -2.6 | 37.4 | -13.9 | -24.5 | 6.5 | 29.6 | 10.4 | 27.0 | -16.8 | 27.1 | 21.9 | -22.1 | +69.2% |
| 2024 | 40.0 | 111.7 | 12.0 | 87.0 | 14.9 | 33.3 | 25.2 | -2.4 | 32.9 | 92.5 | -4.0 | -2.0 | +2694.9% |
| 2023 | 61.0 | 17.6 | -27.0 | -24.9 | -16.8 | -20.7 | 24.3 | -39.9 | -18.2 | -48.9 | -5.9 | 57.1 | −68.4% |
| 2022 | -23.3 | 2.0 | -12.0 | -30.0 | -5.1 | -38.2 | 28.6 | -37.0 | -13.9 | 17.3 | -59.8 | -36.2 | −94.1% |
| 2021 | 13.3 | 60.0 | -25.6 | -9.0 | -6.6 | 10.7 | -19.5 | -15.8 | -20.1 | 6.3 | -17.3 | -33.1 | −59.6% |
| 2020 | 7.8 | +7.8% |
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Buy / hold / sell counts